T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY (WITH T:CONNECT MOBILE APP)

by TANDEM DIABETES CARE

DiabetesFDA 510kOn market since 2015
40
Elevated

The T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY (WITH T:CONNECT MOBILE APP) by TANDEM DIABETES CARE has a safety score of 40 out of 100, placing it in the elevated-risk category. Based on FDA MAUDE data, there have been 265,834 adverse event reports including 31 deaths since its introduction in 2015. With an estimated 0 units in use, the incident rate is 0 per 10,000 units. It ranks #205 out of 221 devices in the Diabetes category.

Should you be concerned? A safety score of 40/100 warrants careful consideration. With 265,834 adverse event reports and 31 associated deaths, the risk profile is elevated compared to alternatives in the diabetes category (which averages 68/100). Ask your doctor about alternative devices with better safety records.

No recalls have been issued for this device — a positive indicator of manufacturing quality and design safety. On the market since 2015, this device has 11 years of real-world data — enough for long-term safety patterns to emerge.

Questions to Ask Your Doctor About the T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY (WITH T:CONNECT MOBILE APP)

1. “What alternatives exist to the T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY (WITH T:CONNECT MOBILE APP)?”This device ranks #205 of 221 in the Diabetes category. There are 204 devices with better safety scores — ask if any are appropriate for your case.

2. “How many of these have you personally implanted or used?”Surgeon experience with a specific device significantly impacts outcomes. Higher procedure volume correlates with fewer complications.

3. “What are the specific risks for my case?”Overall adverse event rates (0 per 10,000) are averages — your individual risk depends on age, health conditions, and anatomy.

4. “Is there a newer generation of this device available?”The T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY (WITH T:CONNECT MOBILE APP) has been on the market since 2015 (11 years). Newer versions may have improved safety profiles based on lessons from earlier models.

Adverse Events

265,834

Total reports filed with FDA MAUDE

Death Reports

31

Death reports associated with device

Incident Rate

0

Per 10,000 units in use

Recalls

0

No recalls on record

Estimated Units in Use

0

Based on market data estimates

Category Ranking

#205 of 221

In Diabetes by safety score

How This Compares

Safety Score40/100
Category Average
68
This Device
40
Best in Category
83

Important Context

Adverse event reports reflect reported incidents, not confirmed device failures. Higher numbers may indicate greater device usage, better reporting systems, or increased awareness. This data should be one factor in your research — always consult your physician.